Consumer Food · Founded 1973 · www.universalstarch.com · BSE 524408 · · ISIN INE113E01015
No Notes Added Yet
1. Business Overview
Universal Starch-Chem Allied Ltd. is an Indian company primarily engaged in the manufacturing of starch and its derivatives, utilizing maize (corn) as the principal raw material. The company processes maize to produce a range of products including maize starch, liquid glucose, dextrose monohydrate, and various by-products such as maize oil, corn gluten meal, and maize germ. It operates on a business-to-business (B2B) model, supplying these products to diverse industries including food and beverage (confectionery, bakery, soft drinks), pharmaceuticals, textiles, paper, and animal feed. The company makes money by processing maize and selling these value-added starch products and by-products to industrial customers.
2. Key Segments / Revenue Mix
The company's revenue is primarily derived from the sale of:
Maize Starch: Used as a thickening agent, binder, and stabilizer in food, textiles, paper, and pharmaceutical industries.
Liquid Glucose: A common sweetener and humectant in confectionery, jams, jellies, and pharmaceutical syrups.
Dextrose Monohydrate: Used in food as a sweetener, fermentation agent, and in pharmaceuticals for intravenous solutions and tablets.
By-products: Maize oil (edible oil), corn gluten meal (animal feed), and maize germ (for oil extraction).
While specific revenue contribution percentages for each product line are not publicly detailed, the core business revolves around the maize processing value chain, with starch and glucose derivatives forming the bulk of sales.
3. Industry & Positioning
The company operates within the Indian starch industry, which is a vital part of the broader consumer food and industrial chemicals sectors. The industry is competitive, with several established players ranging from large-scale manufacturers to smaller regional units. Universal Starch-Chem Allied Ltd. is generally considered a mid-sized player in this segment, competing with larger, more integrated manufacturers as well as other regional entities. The industry is largely driven by the growth in end-user sectors like packaged foods, pharmaceuticals, and textiles. The market for many of its products is semi-commodity in nature, placing emphasis on cost efficiency, consistent quality, and supply chain reliability.
4. Competitive Advantage (Moat)
For Universal Starch-Chem Allied Ltd., a durable competitive advantage or "moat" is relatively limited due to the commodity nature of many of its base products. Potential sources of competitive advantage, though not explicitly strong, could include:
Operational Efficiency: Ability to convert raw maize into derivatives at a lower cost than competitors due to efficient plant operations, favorable procurement, or technological integration.
Customer Relationships: Long-standing relationships and consistent quality supply to key industrial clients can create some switching costs.
Product Diversification: A comprehensive range of starch and derivative products catering to multiple industries might offer some stability compared to highly specialized players.
However, without significant brand equity in the B2B space or proprietary technology, the moat primarily relies on scale and cost leadership, which can be challenging against larger competitors.
5. Growth Drivers
Key factors that can drive growth for Universal Starch-Chem Allied Ltd. over the next 3-5 years include:
Growing Food Processing Industry: Increasing demand for processed and packaged foods in India directly drives demand for starch, liquid glucose, and dextrose from food manufacturers.
Expansion of Pharmaceutical Sector: Growth in the Indian pharmaceutical industry, particularly in oral solids and intravenous solutions, boosts demand for dextrose and starches.
Industrial Demand: Continued growth in textile, paper, and animal feed industries will support demand for industrial starch and by-products.
Value-Added Products: Potential for developing and marketing more specialized starch derivatives or modified starches could open new revenue streams and higher margins.
Export Opportunities: Tapping into international markets for its products, especially to neighboring countries or regions with growing industrial demand.
6. Risks
Key business risks for the company include:
Raw Material Price Volatility: Maize (corn) is the primary raw material, and its price fluctuations due to weather, crop yields, and government policies directly impact profitability.
Intense Competition: The starch industry is competitive, with many players vying for market share, leading to pricing pressures.
Regulatory & Environmental Compliance: Changes in food safety regulations, environmental norms (e.g., water usage, effluent treatment), or import/export policies can impact operations and costs.
Economic Downturn: A slowdown in the economy can reduce demand from end-user industries (food, textile, paper, pharma), affecting sales volume.
Supply Chain Disruptions: Issues in logistics or availability of raw materials due to unforeseen events can hamper production.
7. Management & Ownership
Universal Starch-Chem Allied Ltd. is a promoter-driven company. The ownership structure typically involves a significant stake held by the founding family or promoter group, indicating active involvement in strategic decision-making and operations. Information regarding the specific quality of management, beyond general corporate governance practices, is usually derived from long-term financial performance and adherence to regulatory standards. The promoter's long-term commitment to the business is generally a key characteristic of such companies.
8. Outlook
Universal Starch-Chem Allied Ltd. operates in a fundamental segment of the Indian economy, providing essential ingredients for various industries. The company is poised to benefit from India's underlying economic growth, especially the expanding food processing, pharmaceutical, and industrial sectors. This demand provides a stable growth trajectory for its products. However, its outlook is tempered by the inherent challenges of operating in a largely commodity-driven market, primarily susceptible to volatility in maize prices, intense competition, and the need for continuous operational efficiency to maintain profitability. Its ability to diversify into higher-margin, specialized starch derivatives or maintain strong cost control will be crucial for sustained long-term growth and improved financial performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 120 | 126 | 145 | 133 | 91 | 129 | 138 | 121 | 97 | 118 |
| Other Income | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| Total Income | 120 | 127 | 147 | 134 | 91 | 129 | 139 | 122 | 98 | 118 |
| Total Expenditure | 116 | 124 | 138 | 128 | 96 | 118 | 130 | 120 | 93 | 108 |
| Operating Profit | 5 | 2 | 9 | 6 | -5 | 11 | 8 | 2 | 5 | 10 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -1 | 6 | 2 | -9 | 7 | 4 | -2 | 1 | 6 |
| Provision for Tax | 0 | -0 | 1 | 1 | -0 | 0 | 1 | 0 | 0 | 1 |
| Profit After Tax | 1 | -1 | 4 | 1 | -8 | 7 | 3 | -3 | 1 | 5 |
| Adjustments | -0 | 0 | 0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -1 | 4 | 1 | -8 | 7 | 3 | -3 | 1 | 5 |
| Adjusted Earnings Per Share | 1.8 | -2.3 | 10.7 | 3.5 | -19.6 | 16.7 | 7 | -6 | 1.8 | 12.5 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 196 | 165 | 214 | 198 | 279 | 264 | 296 | 456 | 516 | 527 | 491 | 474 |
| Other Income | 2 | 3 | 3 | 1 | 2 | 2 | 1 | 2 | 3 | 3 | 1 | 2 |
| Total Income | 198 | 168 | 217 | 199 | 281 | 266 | 297 | 459 | 519 | 530 | 492 | 477 |
| Total Expenditure | 190 | 163 | 215 | 190 | 267 | 254 | 278 | 431 | 498 | 507 | 473 | 451 |
| Operating Profit | 8 | 5 | 2 | 8 | 14 | 12 | 19 | 28 | 20 | 23 | 20 | 25 |
| Interest | 5 | 4 | 4 | 4 | 6 | 7 | 8 | 8 | 7 | 8 | 9 | 9 |
| Depreciation | 5 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 6 | 6 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | -4 | -6 | 1 | 3 | 0 | 7 | 16 | 8 | 9 | 4 | 9 |
| Provision for Tax | -1 | -2 | -2 | 1 | 2 | -0 | 1 | 4 | 2 | 2 | 1 | 2 |
| Profit After Tax | -1 | -2 | -4 | 0 | 1 | 1 | 6 | 11 | 6 | 7 | 3 | 6 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -1 | -2 | -4 | 0 | 1 | 1 | 6 | 11 | 6 | 7 | 3 | 6 |
| Adjusted Earnings Per Share | -2.6 | -4 | -10 | 0.6 | 3.4 | 1.6 | 15.1 | 27.2 | 14.1 | 16.6 | 7.6 | 15.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -7% | 2% | 13% | 10% |
| Operating Profit CAGR | -13% | -11% | 11% | 10% |
| PAT CAGR | -57% | -35% | 25% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -12% | 6% | 14% | 19% |
| ROE Average | 5% | 9% | 13% | 1% |
| ROCE Average | 9% | 12% | 15% | 10% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 10 | 8 | 13 | 13 | 36 | 38 | 41 | 52 | 58 | 67 | 70 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 23 | 21 | 15 | 28 | 29 | 26 | 45 | 41 | 34 | 30 | 29 |
| Other Non-Current Liabilities | 6 | 4 | 5 | 5 | 11 | 11 | 10 | 11 | 11 | 11 | 11 |
| Total Current Liabilities | 51 | 60 | 73 | 58 | 72 | 82 | 79 | 83 | 101 | 116 | 116 |
| Total Liabilities | 90 | 94 | 106 | 104 | 149 | 157 | 175 | 187 | 204 | 224 | 226 |
| Fixed Assets | 44 | 44 | 53 | 50 | 88 | 84 | 86 | 97 | 101 | 103 | 121 |
| Other Non-Current Assets | 4 | 1 | 3 | 3 | 2 | 3 | 7 | 9 | 9 | 11 | 5 |
| Total Current Assets | 42 | 48 | 50 | 51 | 58 | 70 | 83 | 81 | 94 | 110 | 99 |
| Total Assets | 90 | 94 | 106 | 104 | 149 | 157 | 175 | 187 | 204 | 224 | 226 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 6 | 3 | 3 | 2 | 5 | 3 | 6 | 4 | 8 | 7 |
| Cash Flow from Operating Activities | 17 | -4 | 13 | -8 | 11 | 11 | 11 | 34 | -1 | 19 | 23 |
| Cash Flow from Investing Activities | -5 | -2 | -2 | -1 | -18 | -1 | -9 | -18 | -9 | -9 | -18 |
| Cash Flow from Financing Activities | -9 | 3 | -11 | 8 | 10 | -11 | 1 | -18 | 14 | -10 | -5 |
| Net Cash Inflow / Outflow | 3 | -3 | 0 | -0 | 2 | -1 | 3 | -2 | 4 | -1 | -0 |
| Closing Cash & Cash Equivalent | 6 | 3 | 3 | 3 | 5 | 3 | 6 | 4 | 8 | 7 | 7 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -2.6 | -4.04 | -10.04 | 0.59 | 3.37 | 1.57 | 15.14 | 27.23 | 14.05 | 16.63 | 7.65 |
| CEPS(Rs) | 8.66 | 6.43 | -0 | 10.04 | 13.9 | 13.32 | 24.66 | 37.52 | 26.18 | 30.41 | 22.61 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 24.21 | 20.17 | 31.12 | 32.14 | 86.8 | 90.47 | 97.46 | 124.49 | 138.68 | 158.5 | 166.19 |
| Core EBITDA Margin(%) | 2.82 | 1.24 | -0.3 | 3.74 | 4.1 | 3.77 | 6.04 | 5.6 | 3.36 | 3.82 | 3.74 |
| EBIT Margin(%) | 1.54 | 0.24 | -0.93 | 2.26 | 3.29 | 2.74 | 5.04 | 5.16 | 2.95 | 3.31 | 2.76 |
| Pre Tax Margin(%) | -0.98 | -2.16 | -2.66 | 0.45 | 1.1 | 0.16 | 2.44 | 3.46 | 1.57 | 1.75 | 0.87 |
| PAT Margin (%) | -0.53 | -0.98 | -1.88 | 0.12 | 0.51 | 0.25 | 2.15 | 2.51 | 1.14 | 1.33 | 0.65 |
| Cash Profit Margin (%) | 1.77 | 1.56 | -0 | 2.1 | 2.09 | 2.12 | 3.49 | 3.45 | 2.13 | 2.42 | 1.93 |
| ROA(%) | -1.18 | -1.84 | -4.23 | 0.24 | 1.12 | 0.43 | 3.83 | 6.31 | 3.02 | 3.26 | 1.43 |
| ROE(%) | -9.75 | -18.19 | -39.15 | 1.87 | 5.67 | 1.78 | 16.12 | 24.54 | 10.68 | 11.19 | 4.71 |
| ROCE(%) | 6.73 | 0.97 | -4.81 | 9.13 | 12.25 | 8.12 | 15.73 | 22.77 | 13.04 | 12.92 | 9.42 |
| Receivable days | 30.13 | 40.09 | 32.91 | 41.92 | 33.53 | 39.08 | 40.36 | 32.3 | 32.39 | 34.28 | 37.03 |
| Inventory Days | 28.22 | 31.68 | 29.2 | 29.05 | 23.24 | 33.91 | 37.47 | 21.6 | 19.05 | 24.13 | 26.89 |
| Payable days | 81.03 | 105.04 | 100.05 | 116.65 | 68.63 | 87.15 | 97.94 | 66.28 | 55.4 | 54.03 | 58.11 |
| PER(x) | 0 | 0 | 0 | 47.35 | 14.04 | 12.36 | 4.49 | 5.11 | 7.69 | 10.86 | 20.35 |
| Price/Book(x) | 1.18 | 0 | 0.92 | 0.87 | 0.54 | 0.21 | 0.7 | 1.12 | 0.78 | 1.14 | 0.94 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.19 | 0.23 | 0.18 | 0.27 | 0.26 | 0.2 | 0.29 | 0.23 | 0.21 | 0.27 | 0.28 |
| EV/Core EBITDA(x) | 4.76 | 7.73 | 18.19 | 6.22 | 5.26 | 4.28 | 4.56 | 3.76 | 5.44 | 6.08 | 6.96 |
| Net Sales Growth(%) | 6.16 | -15.54 | 29.56 | -7.64 | 40.99 | -5.43 | 12.34 | 54.02 | 12.99 | 2.21 | -6.88 |
| EBIT Growth(%) | -73.36 | -86.75 | -597.97 | 317 | 102.63 | -21.3 | 106.49 | 57.87 | -35.49 | 14.64 | -22.1 |
| PAT Growth(%) | -128.99 | -55.08 | -148.83 | 105.9 | 468.83 | -53.29 | 862.2 | 79.83 | -48.4 | 18.36 | -54.02 |
| EPS Growth(%) | -128.99 | -55.09 | -148.83 | 105.9 | 468.86 | -53.3 | 862.2 | 79.83 | -48.4 | 18.36 | -54.02 |
| Debt/Equity(x) | 3.09 | 4.26 | 2.23 | 3.23 | 1.55 | 1.24 | 1.55 | 0.96 | 1.25 | 1.09 | 1.14 |
| Current Ratio(x) | 0.83 | 0.8 | 0.69 | 0.89 | 0.8 | 0.85 | 1.05 | 0.98 | 0.93 | 0.95 | 0.86 |
| Quick Ratio(x) | 0.61 | 0.48 | 0.46 | 0.63 | 0.52 | 0.5 | 0.64 | 0.71 | 0.61 | 0.62 | 0.56 |
| Interest Cover(x) | 0.61 | 0.1 | -0.54 | 1.25 | 1.5 | 1.06 | 1.94 | 3.03 | 2.14 | 2.13 | 1.46 |
| Total Debt/Mcap(x) | 2.62 | 0 | 2.44 | 3.7 | 2.84 | 5.77 | 2.23 | 0.86 | 1.6 | 0.95 | 1.22 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.91 | 53.91 | 53.91 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.09 | 46.09 | 46.09 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.91 | 53.91 | 53.91 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 | 53.86 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.09 | 46.09 | 46.09 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 | 46.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -7% | +2% | +13% | +10% |
| Operating Profit CAGR | -13% | -11% | +11% | +10% |
| PAT CAGR | -57% | -35% | +25% | — |
| Share Price CAGR | -12% | +6% | +14% | +19% |
| ROE Average | +5% | +9% | +13% | +1% |
| ROCE Average | +9% | +12% | +15% | +10% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.